R&D spending hits global record but shrinks in Switzerland
Although worldwide research and development (R&D) expenditures have reached an all-time high of $782 billion (CHF786 billion), budgets in Switzerland have declined by 10%.
The biggest Swiss companies invested CHF27.7 billion ($27.5 billion) in research overall in 2018. The decline in Swiss investments mainly comes from Basel-based pharmaceutical companies Roche and Novartis. According to PwC, Roche spent around $1 billion less on R&D between 2017 and 2018, going from $11.8 billion to $10.9 billion, while Novartis spent $1.1 billion less, going from $9.6 billion to $8.5 billion.
The two pharma giants are ranked 8th and 12th respectively on PwC’s list of the top 1,000 corporate R&D spenders worldwide between 2012 and 2018, down from 7th and 10th last year. However, they still spent far more than any other Swiss companies. Next on the list were Nestlé, which ranked 94th with R&D investments of $1.8 billion, and engineering group ABB, which ranked 115th with investments of $1.4 billion.
As far as global leaders, Amazon came out on top with $22.6 billion in R&D investments.
However, the study authors also note that companies that have the best reputation as innovators aren’t necessarily those that spend the most on R&D, and that companies that are perceived as being innovative tend to be more financially successful.
“Large investments alone are not enough to promote innovation,” explained Peter Kasahara of PwC Switzerland. “It requires a deep understanding of the needs of end consumers and focusing research projects on the right core areas.”
Popular Stories
More
Workplace Switzerland
Meet the foreigners who make up a quarter of the Swiss population
What can be done to protect biodiversity in your country?
Swiss voters are set to decide on a people’s initiative calling for better protection of ecosystems in the country. Have your say on the September 22 vote.
Researchers throw concrete blocks down Swiss mountain
This content was published on
Researchers are rolling huge chunks of concrete down the slope on the Weissfluhjoch near Davos in eastern Switzerland for scientific purposes.
This content was published on
Almost two-thirds of Swiss people are more frequently concerned with death and the issue of living wills and advance healthcare directives.
Russian shelling kills three Red Cross workers in eastern Ukraine
This content was published on
Russian shelling on Thursday killed three Ukrainians working for the ICRC and wounded two others in a village in the frontline Donetsk region.
Swiss banks fret over sanctions risk to wealth business
This content was published on
A survey of Swiss banks has highlighted international sanctions imposed on other countries, such as against Russia over Ukraine, as the greatest geopolitical risk to their business.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Novartis to cut 2,200 Swiss jobs by 2020
This content was published on
Around 1,500 jobs are affected in production and 700 in services. Novartis currently employs 13,000 people across Switzerland.
Swiss companies are world leaders in innovation spending
This content was published on
Swiss companies are at the front of the pack when it comes to investing in research and development (R&D) worldwide, according to a global business survey. Accounting and consulting firm Ernst & Young (EY) found that Swiss companies spend 6.6% of their turnover on R&D, compared with an average of 3.8% worldwide. The authors of…
This content was published on
Switzerland is home to some of the largest global companies. But what value do they bring to the Swiss economy and society?
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.